Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: Results of a randomized, double-blind, placebo-controlled trial

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Liu, Yunfang ^a   Zhu, Guangying ^b   Han, Li ^c   Liu, Jie ^d   Ma, Ting ^e   Yu, Huiming ^f  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PEKING UNIVERSITY   (China)

^c DALIAN UNIVERSITY   (China)

^d SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^e SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GUILONGTONGLUOFANG; HERBACEOUS AGENT; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL STUDY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DYSESTHESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NEUTROPENIA; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 84890067228     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/541217     Document Type: Article

References (27)

1. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hendler D., De Braud F., Wilson C., Morvan F., Bonetti A., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology 2000 18 16 2938 2947 2-s2.0-0033874892 (Pubitemid 30644117)
2. Giacchetti S., Perpoint B., Zidani R., Le Bail N., Faggiuolo R., Focan C., Chollet P., Llory J. F., Letourneau Y., Coudert B., Bertheaut-Cvitkovic F., Larregain-Fournier D., Le Rol A., Walter S., Adam R., Misset J. L., Lévi F., Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology 2000 18 1 136 147 2-s2.0-0033989203 (Pubitemid 30036347)
3. Khattak M. A., Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity? Oncologist 2011 16 12 1780 1783 2-s2.0-84855181458 10.1634/theoncologist.2011-0157
4. Wilson R. H., Lehky T., Thomas R. R., Quinn M. G., Floeter M. K., Grem J. L., Acute oxaliplatin-induced peripheral nerve hyperexcitability. Journal of Clinical Oncology 2002 20 7 1767 1774 2-s2.0-0036534144 10.1200/JCO.2002.07.056 (Pubitemid 34273265)
5. Cersosimo R. J., Oxaliplatin-associated neuropathy: a review. Annals of Pharmacotherapy 2005 39 1 128 135 2-s2.0-11144242919 10.1345/aph.1E319 (Pubitemid 40052388)
6. Cascinu S., Catalano V., Cordella L., Labianca R., Giordani P., Baldelli A. M., Beretta G. D., Ubiali E., Catalano G., Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology 2002 20 16 3478 3483 2-s2.0-0037102328 10.1200/JCO.2002.07.061
7. Land S. R., Kopec J. A., Cecchini R. S., Ganz P. A., Wieand H. S., Colangelo L. H., Murphy K., Kuebler J. P., Seay T. E., Needles B. M., Bearden J. D. III, Colman L. K., Lanier K. S., Pajon E. R. Jr., Cella D., Smith R. E., O'Connell M. J., Costantino J. P., Wolmark N., Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. Journal of Clinical Oncology 2007 25 16 2205 2211 2-s2.0-34250214962 10.1200/JCO.2006.08.6652 (Pubitemid 46954644)
8. NCI Common Toxicity Criteria, Version 2. 0 1998 Washington, DC, USA National Institutes of Health, National Cancer Institute
9. André T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., Topham C., Zaninelli M., Clingan P., Bridgewater J., Tabah-Fisch I., De Gramont A., Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. The New England Journal of Medicine 2004 350 23 2343 2351 2-s2.0-2542615200 10.1056/NEJMoa032709 (Pubitemid 38702845)
10. Alberts S. R., Horvath W. L., Sternfeld W. C., Goldberg R. M., Mahoney M. R., Dakhil S. R., Levitt R., Rowland K., Nair S., Sargent D. J., Donohue J. H., Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. Journal of Clinical Oncology 2005 23 36 9243 9249 2-s2.0-33644819672 10.1200/JCO.2005.07.740
11. Hochster H., Chachoua A., Speyer J., Escalon J., Zeleniuch-Jacquotte A., Muggia F., Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer. Journal of Clinical Oncology 2003 21 14 2703 2707 2-s2.0-0043132277 10.1200/JCO.2003.02.071 (Pubitemid 46606314)
12. Meijer C., de Vries E. G. E., Marmiroli P., Tredici G., Frattola L., Cavaletti G., Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. NeuroToxicology 1999 20 6 883 887 2-s2.0-0033368580 (Pubitemid 30091215)
13. Kottschade L. A., Sloan J. A., Mazurczak M. A., Johnson D. B., Murphy B. P., Rowland K. M., Smith D. A., Berg A. R., Stella P. J., Loprinzi C. L., The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Supportive Care in Cancer 2011 19 11 1769 1777 2-s2.0-83255166592 10.1007/s00520-010-1018-3
14. Gamelin L., Boisdron-Celle M., Delva R., Guérin-Meyer V., Ifrah N., Morel A., Gamelin E., Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clinical Cancer Research 2004 10 12, part 1 4055 4061 2-s2.0-3042523914 10.1158/1078-0432.CCR-03-0666 (Pubitemid 38812481)
15. Tatsushima Y., Egashira N., Narishige Y., Fukui S., Kawashiri T., Yamauchi Y., Oishi R., Calcium channel blockers reduce oxaliplatin-induced acute neuropathy: a retrospective study of 69 male patients receiving modified FOLFOX6 therapy. Biomedicine & Pharmacotherapy 2013 67 1 39 42
16. Grothey A., Nikcevich D. A., Sloan J. A., Kugler J. W., Silberstein P. T., Dentchev T., Wender D. B., Novotny P. J., Chitaley U., Alberts S. R., Loprinzi C. L., Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. Journal of Clinical Oncology 2011 29 4 421 427 2-s2.0-79952087995 10.1200/JCO.2010.31.5911
17. Wen F., ZhouY, Wang W., Hu Q. C., Liu Y. T., Zhang P. F., Du Z. D., Dai J., Li Q., Ca/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis. Annals of Oncology 2013 24 1 171 178
18. Argyriou A. A., Bruna J., Marmiroli P., Cavaletti G., Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Critical Reviews in Oncology/Hematology 2012 82 1 51 77 2-s2.0-84858799716 10.1016/j.critrevonc.2011.04.012
19. Grisold W., Cavaletti G., Windebank J., Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology 2012 14 supplement 4 45 54
20. Scuteri A., Galimberti A., Ravasi M., Pasini S., Donzelli E., Cavaletti G., Tredici G., NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2. Neuroscience Letters 2010 486 3 141 145 2-s2.0-78049389903 10.1016/j.neulet.2010.09.028
21. Hosokawa A., Ogawa K., Ando T., Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study. Anticancer Research 2012 32 7 2545 2550
22. Zhang Q. A., Fan X. H., Zhang Z. Q., Li T., Zhu C. P., Zhang X. R., Song W., Extraction, antioxidant capacity and identification of Semen Astragali Complanati (Astragalus complanatus R. Br.) phenolics. Food Chemistry 2013 141 2 1295 1300
23. Zhang Q., Gao W. Y., Zhang Y., Chen B. Y., Chen Z., Zhang W. S., Man S. L., Protective effects of astragalus extract against intermittent hypoxia-induced hippocampal neurons impairment in rats. Chinese Medical Journal 2013 126 8 1551 1554
24. Wang J., Tong X., Li P., Cao H., Su W., Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice. Journal of Ethnopharmacology 2012 139 3 788 795 2-s2.0-84856213881 10.1016/j.jep.2011.12.019
25. Zhu Y.-F., Luo H.-M., Deng Z.-L., Fu D.-Y., Yao W., Dai J., Effects of the Chinese patent medicine, Honghua injection, on platelet glycoprotein Tib/Ufa receptors in patients with acute coronary syndrome: a randomized controlled trial. Journal of Chinese Integrative Medicine 2012 10 3 318 323 2-s2.0-84858601227 10. 3736/jcim20120311
26. Koo Y. K., Kim J. M., Koo J. Y., Kang S. S., Bae K., Kim Y. S., Chung J.-H., Yun-Choi H. S., Platelet anti-aggregatory and blood anti-coagulant effects of compounds isolated from Paeonia lactiflora and Paeonia suffruticosa. Pharmazie 2010 65 8 624 628 2-s2.0-77955902352 10.1691/ph.2010.9870
27. Shi J., Wei P. K., Professor Wei Pin-kang's experience in treating chemotherapy induced nausea and vomiting: an analysis of herbal medication. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012 32 4 556 559